Coalesce Capital and Freedom 3 Capital Recapitalize Examinetics

Seaport Capital Recapitalizes Exacom

December 1, 2020

Software

Seaport Capital has made a significant investment to recapitalize Exacom, a developer of multimedia recording and logging solutions for public safety, government, utilities, healthcare and other mission-critical markets. The transaction converts Exacom’s ESOP ownership structure and provides capital to accelerate growth while keeping the existing management team, led by President and CEO Al Brisard, in place.

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.

NMS Capital Recapitalizes Exo Group

July 14, 2020

Infrastructure

NMS Capital has completed a recapitalization of Exo Group, LLC, partnering with Exo's founders and management who will remain significant shareholders. The investment will provide capital to support Exo's growth in data-driven asset inspection, remediation, engineering and training services for steel infrastructure across North America.

Coalesce Capital Majority Recapitalizes Marshall & Stevens

January 6, 2026

Professional Services

Coalesce Capital announced a majority recapitalization of Marshall & Stevens, a leading independent valuation, litigation support, and transaction advisory firm. Management will retain a meaningful ownership stake and Coalesce will support growth through investments in talent, technology, and strategic acquisitions; the transaction closed in December 2025.

Flourish Research / NMS Capital Recapitalize Excel Medical Clinical Trials

October 14, 2021

Healthcare Services

NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.

EXA Capital Acquires PrecisionCare

February 24, 2025

Healthcare Services

EXA Capital has acquired PrecisionCare, a New York–founded SaaS provider of electronic health records and care management solutions serving behavioral health and long-term care providers. PrecisionCare’s management will remain in place as EXA leverages its buy-and-hold strategy and operational resources to accelerate product development, scale market reach, and expand capabilities in healthcare technology.